CIK 0001088856
- Large accelerated filer
CORCEPT THERAPEUTICS INC
Sign in to watch- Ticker
- CORT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 770487658
- Phone
- +1 650-688-8803
- Business address
- 101 REDWOOD SHORES PARKWAY, REDWOOD CITY, CA, 94065
- 4 Derivatives Options or other derivatives
- 4 Planned sale Director sold 2,200 shares at $70.61 ($155,342)
- 4 Planned sale Chief Development Officer sold 20,000 shares at an average $72.42 ($1,448,475)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Planned sale Chief Executive Officer sold 40,000 shares at an average $82.86 ($3,314,310)
- 4 Planned sale See Remarks sold 5,000 shares at an average $78.04 ($390,218)
- 4 Planned sale See Remarks sold 20,000 shares at an average $79.08 ($1,581,686)
- 4 Grant or award Chief Business Officer acquired 1,994 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 1,550 shares (grant or award)
- 4 Option exercise See Remarks acquired 10,000 shares (option exercise)
- 4 Open-market sale Chief Business Officer sold 2,279 shares at $75.85 ($172,862)
- 4 Planned sale Chief Development Officer sold 32,262 shares at $74.17 ($2,393,014)
- 4 Open-market sale Director sold 27,352 shares at an average $74.23 ($2,030,452)
- 4 Planned sale Director sold 2,200 shares at an average $72.06 ($158,526)
- 4 Planned sale Chief Development Officer sold 7,060 shares at $74.31 ($524,653)
- 4 Planned sale See Remarks sold 39,410 shares at an average $72.13 ($2,842,769)
- 4 Planned sale Chief Executive Officer sold 40,000 shares at an average $72.90 ($2,915,922)
- 4 Planned sale See Remarks sold 9,350 shares at $71.96 ($672,781)
Page 8 of 60 · 1,196 filings